Evaluation of the effect of FYX-051 on cardiac repolarization : a thorough QT/QTc study.
Phase 3
- Conditions
- Healthy adult subjects
- Registration Number
- JPRN-jRCT2080221352
- Lead Sponsor
- SANWA KAGAKU KENKYUSHO CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Japanese healthy adult subjects
Body weight:male 50kg or more, female 40kg or more
Exclusion Criteria
Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacodynamics, Pharmacokinetics and Safety
- Secondary Outcome Measures
Name Time Method